BOPA Introduction to Oncology Course Research Published

The BOPA Introduction to Oncology Course Improves Knowledge of Oncology Pharmacy Professionals.

 

A peer-reviewed article has been published on the Journal of Oncology Pharmacy Practice (JOPP) showing that there are overall knowledge gain for Oncology Pharmacy Professionals after attending BOPA’s Introduction to Oncology course.

This study has demonstrated that overall the ITO course improved the baseline knowledge of the delegates attending the course in November 2023 (+1.21). The delegates were also more confident in verifying SACT prescriptions after the course.

Cracknell N, Parbutt C, Wong C, Ganijee T. A study to quantify knowledge obtained during the British Oncology Pharmacy Association (BOPA) Introduction to Oncology (ITO) Course. Journal of Oncology Pharmacy Practice. 2024;0(0). doi:10.1177/10781552241259367 (Complementary assess of this article is available to ISOPP members, join no-fee ISOPP now.)

Well done and congratulations to BOPA members and ITO Chairs, Netty Cracknell fBOPA, Catherine Parbutt mBOPA, Clayton Wong mBOPA and Tasneem Ganijee mBOPA on the publication.


#BOPAITO returns to London on 4th and 5th November 2024. Registration information will be announced soon, interested delegates are advised to seek study leave approval from their employers prior to registration.

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article